CD4 T cells reactive to hybrid insulin peptides are indicators of disease activity in the NOD mouse

60Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We recently established that hybrid insulin peptides (HIPs), formed in islet b-cells by fusion of insulin C-peptide fragments to peptides of chromogranin A or islet amyloid polypeptide, are ligands for diabetogenic CD4 T-cell clones. The goal of this study was to investigate whether HIP-reactive T cells were indicative of ongoing autoimmunity. MHC class II tetramers were used to investigate the presence, phenotype, and function of HIP-reactive and insulin-reactive T cells in NOD mice. Insulin-reactive T cells encounter their antigen early in disease, but they express FoxP3 and therefore may contribute to immune regulation. In contrast, HIP-reactive T cells are proinflam-matory and highly diabetogenic in an adoptive transfer model. Because the frequency of antigen-experienced HIP-reactive T cells increases over progression of disease, they may serve as biomarkers of autoimmune diabetes.

Cite

CITATION STYLE

APA

Baker, R. L., Jamison, B. L., Wiles, T. A., Lindsay, R. S., Barbour, G., Bradley, B., … Haskins, K. (2018). CD4 T cells reactive to hybrid insulin peptides are indicators of disease activity in the NOD mouse. In Diabetes (Vol. 67, pp. 1836–1846). American Diabetes Association Inc. https://doi.org/10.2337/db18-0200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free